this post was submitted on 23 Aug 2024
323 points (99.7% liked)

World News

38971 readers
2465 users here now

A community for discussing events around the World

Rules:

Similarly, if you see posts along these lines, do not engage. Report them, block them, and live a happier life than they do. We see too many slapfights that boil down to "Mom! He's bugging me!" and "I'm not touching you!" Going forward, slapfights will result in removed comments and temp bans to cool off.

We ask that the users report any comment or post that violate the rules, to use critical thinking when reading, posting or commenting. Users that post off-topic spam, advocate violence, have multiple comments or posts removed, weaponize reports or violate the code of conduct will be banned.

All posts and comments will be reviewed on a case-by-case basis. This means that some content that violates the rules may be allowed, while other content that does not violate the rules may be removed. The moderators retain the right to remove any content and ban users.


Lemmy World Partners

News [email protected]

Politics [email protected]

World Politics [email protected]


Recommendations

For Firefox users, there is media bias / propaganda / fact check plugin.

https://addons.mozilla.org/en-US/firefox/addon/media-bias-fact-check/

founded 1 year ago
MODERATORS
 

Doctors have begun trialling the world’s first mRNA lung cancer vaccine in patients, as experts hailed its “groundbreaking” potential to save thousands of lives.

Lung cancer is the world’s leading cause of cancer death, accounting for about 1.8m deaths every year. Survival rates in those with advanced forms of the disease, where tumours have spread, are particularly poor.

Now experts are testing a new jab that instructs the body to hunt down and kill cancer cells – then prevents them ever coming back. Known as BNT116 and made by BioNTech, the vaccine is designed to treat non-small cell lung cancer (NSCLC), the most common form of the disease.

The phase 1 clinical trial, the first human study of BNT116, has launched across 34 research sites in seven countries: the UK, US, Germany, Hungary, Poland, Spain and Turkey.

you are viewing a single comment's thread
view the rest of the comments
[–] [email protected] 1 points 2 months ago (4 children)

Any idea yet how long it might last? Could this ever be something that we take young (either as kids or now in my 30s) and just not be afraid of lung cancer?

[–] [email protected] 10 points 2 months ago* (last edited 2 months ago) (1 children)

Unless this one works differently than the one I read about a month or so ago, which isn’t at all clear from this article, no, probably not something we can get as kids.

The reason is that, at least at the moment, you need a sample of the cancer itself and protein markers for each individual, and each cancer type, so it’s a vaccine that you get only after you get the cancer. Plus it’s multiple doses over the course of several weeks.

They also aren’t sure if the cancer will come back after being eradicated, so for now they have no idea how effective it will be, nor how long it’ll last.

But this is a technology very much in its infancy. The first trial ever was earlier this year, so… who knows where it’ll go from there. Maybe they will be able to isolate enough common markers for enough cancers to have a childhood vax for prevention. Almost certainly a long ways off tho.

[–] [email protected] 4 points 2 months ago (1 children)

If it's a post disease treatment isn't it just a cure vs a vaccine then?

load more comments (2 replies)